Myles Greenberg

Chief Executive Officer at

InCarda Therapeutics, Inc.

58 year

98 connections

Health Technology

Consumer Services

Commercial Services

Profile

Myles D.
Greenberg is currently Chief Executive Officer at InCarda Therapeutics, Inc. since 2024.
He is a Director at Urgent Care Centers of New England, Inc. He is a Partner at CHL Healthcare Partners LLC since 2013 and a Venture Partner at Healthinvest Equity Partners.
Formerly, Dr. Greenberg was President, Chief Executive Officer & Director at Alucent Biomedical Inc. from 2017 to 2024.
He served as Chairman at Cantex Pharmaceuticals, Inc. and held Director positions at Oriel Therapeutics, Inc., Angiomics, Inc., Millennium Pharmacy Systems, Inc., NuVasive LLC, Dynogen Pharmaceuticals, Inc., Vertos Medical, Inc., Ivrea Pharmaceuticals, Inc., Oculir, Inc., DICOM Grid, Inc., FlowCardia, Inc., and Mevion Medical Systems, Inc. as an Independent Director.
He was Assistant Clinical Director-Emergency Department at Beth Israel Deaconess Medical Center, Inc. and Assistant Clinical Director-Emergency Medicine at Harvard Medical School.
He was Senior Principal at Pappas Capital LLC from 2000 to 2003 and Assistant Professor at UNC School of Medicine.
Education includes an MBA from Harvard Business School in 2000, a doctorate from Yale School of Medicine in 1993, and an undergraduate degree from the School of Engineering & Applied Science in 1989.

Myles Greenberg active positions

Companies	Position	Start
CHL Healthcare Partners LLC CHL Healthcare Partners LLC Investment ManagersFinance CHL Healthcare Partners invests in companies located in the US. The firm targets companies operating in a broad range of sectors. It provides financing for seed and early stage capital requirements with an investment size ranging from USD 0.1 - 7.5 million. It makes control investments and has a board seat requirements.	Private Equity Investor	01/01/2004
Urgent Care Centers of New England, Inc. Urgent Care Centers of New England, Inc. Medical/Nursing ServicesHealth Services Provides urgent care services	Director/Board Member	-
Healthinvest Equity Partners Healthinvest Equity Partners Investment ManagersFinance Healthinvest Equity seeks investment opportunities in companies located in the United States. The firm targets companies operating in the fields of healthcare service sector. It provides financing for early stage capital requirements.	Private Equity Investor	-
InCarda Therapeutics, Inc. InCarda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company that develops and manufactures innovative therapies for atrial fibrillation & cardiac rhythm disorders	Chief Executive Officer	10/12/2024

All active positions of Myles Greenberg

Former positions of Myles Greenberg

Companies	Position	End
Alucent Biomedical Inc. Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biomedical company	Chief Executive Officer	02/11/2024
Oculir, Inc. Oculir, Inc. Medical SpecialtiesHealth Technology Develops medical devices	Director/Board Member	23/10/2008
Pappas Capital LLC Pappas Capital LLC Investment ManagersFinance Pappas Ventures invests in companies located in the across the globe and primarily in United States, Canada and Asia. The firm focuses on next-generation life science, agriculture, and technology. It participates in seed and early-stage transactions.	Corporate Officer/Principal	31/12/2003
Millennium Pharmacy Systems, Inc. Millennium Pharmacy Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical management services	Director/Board Member	-
NUVASIVE, INC.	Director/Board Member	-

See the detail of Myles Greenberg's experience

Training of Myles Greenberg

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Myles Greenberg's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	24
Oriel Therapeutics, Inc. Oriel Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled drug delivery systems for respiratory diseases and diagnostics	Health Technology
Angiomics, Inc.
Millennium Pharmacy Systems, Inc. Millennium Pharmacy Systems, Inc. Miscellaneous Commercial ServicesCommercial Services Provides pharmaceutical management services	Commercial Services
NuVasive, Inc. NuVasive, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices for the surgical treatment of spine disorders	Health Technology
Dynogen Pharmaceuticals, Inc. Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs	Health Technology
Mevion Medical Systems, Inc. Mevion Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops proton therapy systems to treat cancer	Health Technology
Vertos Medical, Inc. Vertos Medical, Inc. Medical SpecialtiesHealth Technology Develops and markets invasive devices for treatment of lumbar spinal stenosis	Health Technology
Ivrea Pharmaceuticals, Inc. Ivrea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for dermatologic conditions	Health Technology
Oculir, Inc. Oculir, Inc. Medical SpecialtiesHealth Technology Develops medical devices	Health Technology
DICOM Grid, Inc. DICOM Grid, Inc. Packaged SoftwareTechnology Services Develops medical data and image management SaaS platform	Technology Services
Cantex Pharmaceuticals, Inc. Cantex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops heparin to ameliorate cardiac ischemia-reperfusion injuries	Health Technology
Pappas Capital LLC Pappas Capital LLC Investment ManagersFinance Pappas Ventures invests in companies located in the across the globe and primarily in United States, Canada and Asia. The firm focuses on next-generation life science, agriculture, and technology. It participates in seed and early-stage transactions.	Finance
CHL Healthcare Partners LLC CHL Healthcare Partners LLC Investment ManagersFinance CHL Healthcare Partners invests in companies located in the US. The firm targets companies operating in a broad range of sectors. It provides financing for seed and early stage capital requirements with an investment size ranging from USD 0.1 - 7.5 million. It makes control investments and has a board seat requirements.	Finance
Beth Israel Deaconess Medical Center, Inc. Beth Israel Deaconess Medical Center, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services	Health Services
FlowCardia, Inc. FlowCardia, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures endovascular devices	Health Technology
Harvard Medical School Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
InCarda Therapeutics, Inc. InCarda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biopharmaceutical company that develops and manufactures innovative therapies for atrial fibrillation & cardiac rhythm disorders	Commercial Services
Urgent Care Centers of New England, Inc. Urgent Care Centers of New England, Inc. Medical/Nursing ServicesHealth Services Provides urgent care services	Health Services
Harvard Business School Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Yale School of Medicine Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
School of Engineering & Applied Science School of Engineering & Applied Science Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
UNC School of Medicine UNC School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Healthinvest Equity Partners Healthinvest Equity Partners Investment ManagersFinance Healthinvest Equity seeks investment opportunities in companies located in the United States. The firm targets companies operating in the fields of healthcare service sector. It provides financing for early stage capital requirements.	Finance
Alucent Biomedical Inc. Alucent Biomedical Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biomedical company	Commercial Services